Back to Search
Start Over
Can the Combination of the Measurement of BCR-ABL1 Transcript Levels At 3 and 6 Months Improve the Prognostic Value of the 3 Month Measurement?
- Source :
- Blood; November 2012, Vol. 120 Issue: 21 p68-68, 1p
- Publication Year :
- 2012
-
Abstract
- Goldman: Novartis, Bristol Myers-Squibb, and Amgen: Honoraria. Marin:BMS: Research Funding; Novartis: Research Funding.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 120
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs53010958
- Full Text :
- https://doi.org/10.1182/blood.V120.21.68.68